Sales and Marketing

Showing 15 posts of 11528 posts found.

Ipsen announces new Vice President of Corporate External Communications

September 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Mental health crisis as UK struggles with number of psychiatrists

September 11, 2017 Business Services, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical, psychiatry

Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …

Lilly’s Cyramza combo boasts strong results in bladder cancer

September 11, 2017 Research and Development, Sales and Marketing Eli Lilly, bladder cancer, cyramza, immunotherapy, pharma

Eli Lilly has announced new Phase 3 data at the European Society for Medical Oncology 2017 Congress which further add …

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017 Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

AstraZeneca’s Tagrisso beats standard of care in halting NSCLC

September 11, 2017 Research and Development, Sales and Marketing AstraZeneca, ESMO, NSCLC, Tagrisso, non-small cell cell cancer, pharma, pharmaceutical

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …

Teva finally announces successful CEO appointment

September 11, 2017 Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical

Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …

Casebia Therapeutics bolsters leadership by bringing in two new faces

September 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, CRISPR Therapeutics, Casebia Therapeutics, biotech, drugs, pharma, pharmaceutical

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …

Top Ten most popular articles on Pharmafile.com this week

September 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

This week saw a number of hard-hitting stories hit the headlines that are sure to have resonant consequences. Following the …

Lily announces massive staff cuts of 3,500 to “streamline business”

September 8, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing

In a drastic bid to “streamline business, invest in new medicines and drive”, Eli Lilly has announced major staff cuts …

Spotting Leukaemia

September 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …

BMS hit by clinical trial hold from FDA

September 7, 2017 Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, immunotherapy, opdivo, pharma, pharmaceutical

The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination …

MSD plays catch up with €464m deal for fledgling biotech

September 7, 2017 Sales and Marketing Bristol-Myers Squibb, MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD has announced that it will acquire Rigontec, a three-year old German biotech, in a deal worth an initial €115 …

Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million

September 6, 2017 Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical

Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …

Novartis exec designated as new CEO after Jimenez announces retirement

September 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …
The Gateway to Local Adoption Series

Latest content